Venkatesh Alapati, MD

Ticagrelor vs Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Insights From a Single Institution Registry

07/14/2019

Sorin J. Brener , MD;

Terrence J. Sacchi , MD;

Venkatesh Alapati , MD;

Max M. Benson , MD;

Doris Chan , DO;

Gregory J. Cunn , MD;

Saadat Khan , MD;

Issa Kutkut , MD;

John P. O'Laughlin , MD;

Chockalingham Arun Narayanan , MD;

We identified ACS patients from our institutional registry who underwent PCI and received either ticagrelor or clopidogrel and compared 1-year all-cause death rates.

We identified ACS patients from...

07/14/2019

Journal of Invasive Cardiology

Original Contribution

The SYNTAX II Score Predicts Mortality at 4 Years in Patients Undergoing Percutaneous Coronary Intervention

06/15/2018

Amol Raizada , MD;

Terrence J. Sacchi , MD;

Venkatesh Alapati , MD;

Doris Chan , DO;

John P. O'Laughlin , MD;

Akanibo Da-Wariboko , MD;

Sorin J. Brener , MD;

Yousef Kaid , MD;

Chockalingham Arun Narayanan , MD;

Yevgeniy Latyshev , MD;

Amr Moussa , MD;

Gautam Verma , MD;

We evaluate the utility of the SYNTAX II score, which incorporates angiographic and clinical parameters, for risk stratification and prediction of 4-year mortality in 831 real-world patients.

We evaluate the utility of...

06/15/2018

Journal of Invasive Cardiology